Skip to main content

Advertisement

SpringerLink
Log in

Current opinion on the role of resection and liver transplantation for hepatocellular cancer

  • Review Article
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Hepatocellular carcinoma (HCC) represents one of the most common cancers worldwide with rising incidence in developed countries. The best treatment options with curative intent for patients with HCC are liver resection or transplantation, although the role of hepatic ablative therapies has also been recognized. Surgical resection has emerged as the primary treatment in carefully selected patients of HCC. With the advances in surgical and radiological techniques, the perioperative mortality has been reduced to less than 5 % depending on the extent of resection and hepatic reserve. The role of liver transplantation (LT) as the mainstay of treatment for the majority of patients with HCC has evolved in the last few decades. Historically, the Milan criteria have been considered the gold standard for selecting patients; more expanded selection criteria to include those with more advanced tumors have been implemented in recent years. Living donor liver transplantation (LDLT) has emerged as a way to expand the donor pool and has influenced the role of transplantation for HCC, especially in communities with little access to cadaveric transplantation. Salvage transplantation is an alternative option as it allows a window for the biologically less favorable lesions to declare tumor behavior. Salvage transplantation also decreases the burden on transplant resources. Sirolimus, a novel immunosuppressant drug with anti-tumor effect, may have a role in limiting the severity of recurrent disease after transplantation for HCC, and play an important role in the future management of transplant recipients. This article examines the literature on current status of management of HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lau WY, Lai ECH. Hepatocellular carcinoma: current management and recent advances. Hapatobiliary Pancreat Dis Int. 2008;7:237–57.

    Google Scholar 

  2. Villa VD, Lo CM. Liver transplantation for hepatocellular carcinoma in Asia. Oncologist. 2007;12:1321–31.

    Article  PubMed  Google Scholar 

  3. Polak WG, Soyama A, Slooff MJH. Liver transplantation in patients with hepatocellular carcinoma. Ann Transplant. 2008;13:5–15.

    PubMed  Google Scholar 

  4. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–6.

    Article  PubMed  CAS  Google Scholar 

  5. Rampone B, Schiavone B, Martino A, Viviano C, Confuoto G. Current management strategy of hepatocellular carcinoma. World J Gastroenterol. 2009;14:3210–6.

    Article  CAS  Google Scholar 

  6. Liu JH, Chen PW, Asch SM, Busuttil RW, Ko CY. Surgery for hepatocellular carcinoma: does it improve survival? Ann Surg Oncol. 2004;11:298–303.

    Article  PubMed  Google Scholar 

  7. Fattovich G, Stroffolini T, Zagni I, et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gatroenterology. 2004;1275 Suppl 1:S35–50.

    Article  Google Scholar 

  8. Yamazaki S, Takayama T. Surgical treatment of hepatocellular carcinoma: evidence based outcomes. World J Gastroenterol. 2008;14:685–92.

    Article  PubMed  Google Scholar 

  9. Poon RTP, Fan ST, Mau C, Wang J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function. Ann Surg. 2002;235:373–82.

    Article  PubMed  Google Scholar 

  10. Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma patient selection and postoperative outcome. Liver Transpl. 2004;102 Suppl 1:S39–45.

    Article  PubMed  Google Scholar 

  11. Mazzaferro V. Results of liver transplantation: with or without Milan criteria? Liver Transpl. 2007;13:S44–7.

    Article  PubMed  Google Scholar 

  12. Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol. 1996;167:759–68.

    PubMed  CAS  Google Scholar 

  13. Guglielmi A, Ruzzenente A, Battocchia A, Tonon A, Fracastoro G, Cordiano C. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology. 2003;50:480–4.

    PubMed  Google Scholar 

  14. Lopez PM, Villanueva A, Roayale S, Llovet JM. Neoadjuvant therapies for hepatocellualr carcinoma before liver transplantation: a critical appraisal. Liver Transplant. 2006;12:1747–57.

    Article  Google Scholar 

  15. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona 2000 EASL conference. J Hepatol. 2001;35:421–30.

    Article  PubMed  CAS  Google Scholar 

  16. Bruix J, Sherman M, for the Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2006;43:373.

    Google Scholar 

  17. Chow PK. Resection for hepatocellular carcinoma: is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria? J Gastroenterol Hepatol. 2012;27:452–7.

    Article  PubMed  Google Scholar 

  18. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.

    Article  PubMed  Google Scholar 

  19. Landman MP, Feurer ID, Pinson CW, Moore DE. Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria? HPB (Oxford). 2011;13:783–91.

    Article  Google Scholar 

  20. Rahbari NN, Mehrabi A, Mollberg NM, et al. Hepatocellular carcinoma current management and perspectives for the future. Ann Surg. 2011;253:453–69.

    Article  PubMed  Google Scholar 

  21. Makuuchi M, Sano K. The surgical approach to HCC: our progress and results in Japan. Liver Transpl. 2004;10:S46–52.

    Article  PubMed  Google Scholar 

  22. Makuuchi M, Kosuge T, Takayama T, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9:298–304.

    Article  PubMed  CAS  Google Scholar 

  23. Kubota K, Makuuchi M, Kusaka K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997;26:1176–81.

    PubMed  CAS  Google Scholar 

  24. Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188:304–9.

    Article  PubMed  CAS  Google Scholar 

  25. Stockmann M, Lock JF, Riecke B, et al. Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg. 2009;250:119–25.

    Article  PubMed  Google Scholar 

  26. Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg. 1999;229:210–5.

    Article  PubMed  CAS  Google Scholar 

  27. Bruix J, Castells A, Bosch J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996;111:1018–22.

    Article  PubMed  CAS  Google Scholar 

  28. Stremitzer S, Tamandl D, Kaczirek K, et al. Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma. Br J Surg. 2011;98:1752–8.

    Article  PubMed  CAS  Google Scholar 

  29. Vauthey JN, Chaoui A, Do KA, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000;127:512–9.

    Article  PubMed  CAS  Google Scholar 

  30. Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg. 2003;138:1198–206.

    Article  PubMed  Google Scholar 

  31. Sugawara Y, Yamamoto J, Higashi H, et al. Preoperative portal embolization in patients with hepatocellular carcinoma. World J Surg. 2002;26:105–10.

    Article  PubMed  Google Scholar 

  32. Farges O, Belghiti J, Kianmanesh R, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg. 2003;237:208–17.

    PubMed  Google Scholar 

  33. Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247:49–57.

    Article  PubMed  Google Scholar 

  34. Bismuth H, Houssin D, Ornowski J, Meriggi F. Liver resections in cirrhotic patients: a Western experience. World J Surg. 1986;10:311–7.

    Article  PubMed  CAS  Google Scholar 

  35. Gozzetti G, Mazziotti A, Cavallari A, et al. Clinical experience with hepatic resections for hepatocellular carcinoma in patients with cirrhosis. Surg Gynecol Obstet. 1988;166:503–10.

    PubMed  CAS  Google Scholar 

  36. Capussotti L, Borgonovo G, Bouzari H, Smadja C, Grange D, Franco D. Results of major hepatectomy for large primary liver cancer in patients with cirrhosis. Br J Surg. 1994;81:427–31.

    Article  PubMed  CAS  Google Scholar 

  37. Nagasue N, Yukaya H, Kohno H, Chang YC, Nakamura T. Morbidity and mortality after major hepatic resection in cirrhotic patients with hepatocellular carcinoma. HPB Surg. 1998;1:45–56.

    Article  Google Scholar 

  38. Belghiti J, Regimbeau JM, Durand F, et al. Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology. 2002;49:41–6.

    PubMed  CAS  Google Scholar 

  39. Grazi GL, Ercolani G, Pierangeli F, et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg. 2001;234:71–8.

    Article  PubMed  CAS  Google Scholar 

  40. Hanazaki K, Kajikawa S, Shimozawa N. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg. 2000;191:381–8.

    Article  PubMed  CAS  Google Scholar 

  41. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg. 1999;229:790–9.

    Article  PubMed  CAS  Google Scholar 

  42. Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 1999;19:311–22.

    Article  PubMed  CAS  Google Scholar 

  43. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434–40.

    Article  PubMed  CAS  Google Scholar 

  44. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg. 1998;228:479–90.

    Article  PubMed  CAS  Google Scholar 

  45. Figueras J, Jaurrieta E, Valls C, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology. 1997;25:1485–9.

    Article  PubMed  CAS  Google Scholar 

  46. Figueras J, Jaurrieta E, Valls C, et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg. 2000;190:580–7.

    Article  PubMed  CAS  Google Scholar 

  47. Poon RT, Fan ST, Lo CM, et al. Long term prognosis after resection of hepatocellular carcinoma associated with hepatitis B related cirrhosis. J Clin Oncol. 2001;18:1094–101.

    Google Scholar 

  48. Koniaris LG, Levi DM, Pedroso FE, et al. Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma. Ann Surg. 2011;253:527–38.

    Article  Google Scholar 

  49. Sugo H, Ishizaki Y, Yoshimoto J, Imamura H, Kawasaki S. Salvage hepatectomy for local recurrent hepatocellular carcinoma after ablation therapy. Ann Surg Oncol. 2012 Feb 1. [Epub ahead of print]

  50. Sakata J, Shirai Y, Wakai T, Kaneko K, Hatakeyama K. Long-term outcomes after hepatectomy for recurrences after prior local ablation for hepatocellular carcinoma. Eur J Surg Oncol. 2008;34:433–8.

    Article  PubMed  CAS  Google Scholar 

  51. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg. 1991;15:270–85.

    Article  PubMed  CAS  Google Scholar 

  52. Iwatsuki S, Starzl TE, Sheahan DG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg. 1991;214:221–8.

    Article  PubMed  CAS  Google Scholar 

  53. Iwatsuki S, Gordon RD, Shaw Jr BW, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg. 1985;202:401–7.

    Article  PubMed  CAS  Google Scholar 

  54. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–9.

    Article  PubMed  CAS  Google Scholar 

  55. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology. 2001;33:1080–6.

    Article  PubMed  CAS  Google Scholar 

  56. Llovet JM, Bruix J, Gores GJ. Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy. Hepatology. 2000;31:1019–21.

    Article  PubMed  CAS  Google Scholar 

  57. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33:1394–403.

    Article  PubMed  CAS  Google Scholar 

  58. Herrero JI, Sangro B, Quiroga J, et al. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl. 2001;7:631–6.

    Article  PubMed  CAS  Google Scholar 

  59. Cillo U, Vitale A, Bassanello M, et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg. 2004;239:150–9.

    Article  PubMed  Google Scholar 

  60. Decaens T, Roudot Thaoraval F, Hadni Bresson S, et al. Impact of UCSF criteria according to pre and post tumor feature: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl. 2006;12:1761–9.

    Article  PubMed  Google Scholar 

  61. Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10:35–43.

    Article  PubMed  Google Scholar 

  62. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005;25:181–200.

    Article  PubMed  Google Scholar 

  63. Samuel D, Colombo M, El-Serag H, Sobesky R, Heaton N. Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma. Liver Transpl. 2011;17 Suppl 2:S6–S13.

    Article  PubMed  Google Scholar 

  64. Takada Y, Uemoto S. Liver transplantation for hepatocellular carcinoma: the Kyoto experience. J Hepatobiliary Pancreat Sci. 2010;17:527–32.

    Article  PubMed  Google Scholar 

  65. Protocols and guidelines for adults undergoing deceased donor liver transplantation in the UK. 2009 September, Version 1:1–12.

    Google Scholar 

  66. Kishi Y, Hasegawa K, Sugawara Y, Kokudo N. Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection. Int J Hepatol. 2011;2011:728103.

    PubMed  Google Scholar 

  67. Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis. 2007;25:310–2.

    Article  PubMed  Google Scholar 

  68. Soejima Y, Taketomi A, Yoshizumi T, et al. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation. 2007;83:893–9.

    Article  PubMed  Google Scholar 

  69. Ito T, Takada Y, Ueda M, et al. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl. 2007;13:1637–44.

    Article  PubMed  Google Scholar 

  70. Taketomi A, Sanefuji K, Soejima Y, et al. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation. 2009;87:531–7.

    Article  PubMed  Google Scholar 

  71. Zheng SS, Xu X, Wu J, et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation. 2008;85:1726–32.

    Article  PubMed  CAS  Google Scholar 

  72. Audet M, Panaro F, Piardi T, Wolf P. Are the Hangzhou criteria adaptable to hepatocellular carcinoma patients for liver transplantation in Western countries? Liver Transpl. 2009;15:822–3.

    Article  PubMed  Google Scholar 

  73. Lee SG, Hwang S, Moon DB, et al. Expanded indication criteria of living donor liver transplantation for hepatocellualr carcinoma at one large-volume center. Liver Transpl. 2008;14:935–45.

    Article  PubMed  Google Scholar 

  74. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–36.

    Article  PubMed  Google Scholar 

  75. Hussain HK, Syed I, Nghiem HV, et al. T2 weighted MR imaging in the assessment of cirrhotic liver. Radiology. 2004;230:637–44.

    Article  PubMed  Google Scholar 

  76. Laghi A, Iannaccone R, Rossi P, et al. Hepatocellular carcinoma: detection with triple phase multidetector row helical CT in patients with chronic hepatitis. Radiology. 2003;226:543–9.

    Article  PubMed  Google Scholar 

  77. Maluf DG, Stravitz RT, Williams B, et al. Multimodality therapy and liver transplantation in patients with cirrhosis and hepatocellular carcinoma: 6 year, single center experience. Transplant Proc. 2007;39:153–9.

    Article  PubMed  CAS  Google Scholar 

  78. Martin AP, Goldstein RM, Dempster J, et al. Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation—a clinical and histological examination. Clin Transplant. 2006;20:695–705.

    Article  PubMed  Google Scholar 

  79. Zimmerman MA, Ghobrial RM, Tong MJ, et al. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg. 2008;143:182–8.

    Article  PubMed  Google Scholar 

  80. Margarit C, Charco R, Hidalgo E, Allende H, Castells LL, Bilbao I. Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg. 2002;26:257–63.

    Article  PubMed  Google Scholar 

  81. Young AL, Malik HZ, Abu-Hilal M, et al. Large hepatocellular carcinoma: time to stop preoperative biopsy. J Am Coll Surg. 2007;205:453–62.

    Article  PubMed  Google Scholar 

  82. Durand F, Belghiti J, Paradis V. Liver transplantation for hepatocellular carcinoma: role of biopsy. Liver Transpl. 2007;13:S17–23.

    Article  PubMed  Google Scholar 

  83. Pawlik TM, Gleisner AL, Anders RA, et al. Preoperative assessment of hepatocellular carcinoma tuomur grade using needle biopsy: implication for transplant eligibility. Ann Surg. 2007;245:435–42.

    Article  PubMed  Google Scholar 

  84. Cillo U, Vitale A, Griggoletto F, et al. Intention to treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria. Am J Transplant. 2007;7:972–81.

    Article  PubMed  CAS  Google Scholar 

  85. Yao FY, Bass NM, Nikolai B, et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl. 2002;8:873–83.

    Article  PubMed  Google Scholar 

  86. Sarasin FP, Giostra E, Mentha G, Hadengue A. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology. 1998;28:436–42.

    Article  PubMed  CAS  Google Scholar 

  87. Saab S, Wang V, Ibrahim AB, et al. MELD score predicts 1-year patient survival postorthotopic liver transplantation. Liver Transpl. 2003;9:473–6.

    Article  PubMed  Google Scholar 

  88. Yao FY, Bass NM, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver Transpl. 2004;10:621–30.

    Article  PubMed  Google Scholar 

  89. Sharma P, Balan V, Hernandez JL, et al. Liver transplantation for hepatocellualr carcinoma: the MELD impact. Liver Transpl. 2004;10:36–41.

    Article  PubMed  Google Scholar 

  90. Sarasin FP, Majno PE, Llovet JM, Bruix J, Mentha G, Hadengue A. Living donor liver transplantation for early hepatocellular carcinoma: a life expectancy and cost effectiveness perspective. Hepatology. 2001;33:1073–9.

    Article  PubMed  CAS  Google Scholar 

  91. Helton WS, Di Bisceglie A, Chari R, Schwartz M, Bruix J. Treatment strategies for hepatocellular carcinoma in cirrhosis. J Gastrointest Surg. 2003;7:401–11.

    Article  PubMed  Google Scholar 

  92. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35:519–24.

    Article  PubMed  Google Scholar 

  93. Van Kleek EJ, Schwartz JM, Rayhill SC, Rosen HR, Cotler SJ. Liver transplantation for hepatocellular carcinoma: a survey of practices. J Clin Gastroenterol. 2006;40:643–7.

    Article  PubMed  Google Scholar 

  94. Todo S, Furukawa H, on behalf of the Japanese study group on organ transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma experience in Japan. Ann Surg. 2004;240:451–61.

    Article  PubMed  Google Scholar 

  95. Broering DC, Wilms C, Bok P, et al. Evolution of donor morbidity in living related liver transplantation: a single-center analysis of 165 cases. Ann Surg. 2004;240:1013–24. discussions 1024−6.

    Article  PubMed  Google Scholar 

  96. Trotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med. 2002;346:1074–82.

    Article  PubMed  Google Scholar 

  97. Umeshita K, Fujiwara K, Kiyosawa K, et al. Operative morbidity of living liver donors in Japan. Lancet. 2003;362:687–90.

    Article  PubMed  Google Scholar 

  98. Lee Jr FT. Treatment of hepatocellular carcinoma in cirrhosis: locoregional therapies for bridging to liver transplant. Liver Transpl. 2007;13:S24–6.

    Article  PubMed  Google Scholar 

  99. Lu DS, Yu NC, Raman SS, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology. 2005;41:1130–7.

    Article  PubMed  Google Scholar 

  100. Lesurtel M, Mullhaupt B, Pestalozzi BC, Pfammatter T, Clavien PA. Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis. Am J Transpl. 2006;6:2644–50.

    Article  CAS  Google Scholar 

  101. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–36.

    Article  PubMed  Google Scholar 

  102. Scatton O, Zalinski S, Terris B, et al. Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation. Liver Transpl. 2008;14:779–88.

    Article  PubMed  Google Scholar 

  103. Majno PE, Sarasin FP, Mentha G, Hadengue A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology. 2000;31:899–906.

    Article  PubMed  CAS  Google Scholar 

  104. Vennarecci G, Ettorre GM, Antonini M, et al. First-line liver resection and salvage liver transplantation are increasing therapeutic strategies for patients with hepatocellular carcinoma and Child A cirrhosis. Transplant Proc. 2007;39:1857–60.

    Article  PubMed  CAS  Google Scholar 

  105. Belghiti J, Cortes A, Abdalla EK, et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg. 2003;238:885–92. discussion 892−3.

    Article  PubMed  Google Scholar 

  106. Margarit C, Escartin A, Castells L, Vargas V, Allende E, Bilbao I. Resection for hepatocellular carcinoma is a good option in Child Turcotte Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl. 2005;11:1242–51.

    Article  PubMed  Google Scholar 

  107. Adam R, Azoulay D, Castaing D, et al. Liver resection as bridge to liver transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg. 2002;238:508–19.

    Google Scholar 

  108. Tanaka H, Kubo S, Tsukamoto T, et al. Recurrence rate and transplantability after liver resection in patients with hepatocellular carcinoma who initially met transplantation criteria. Transplant Proc. 2005;37:1254–6.

    Article  PubMed  CAS  Google Scholar 

  109. Fuks D, Dokmak S, Paradis V, Diouf M, Durand F, Belghiti J. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology. 2012;55:132–40.

    Article  PubMed  Google Scholar 

  110. Cucchetti A, Vital A, Gaudion MD, et al. Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transpl. 2010;10:619–27.

    Article  CAS  Google Scholar 

  111. Toso C, Merani S, Bigam DL, Shapiro AM, Kneteman NM. Sirolimus based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma. Hepatology. 2010;51:1237–43.

    Article  PubMed  CAS  Google Scholar 

  112. Vivarelli M, Cucchetti A, La BG, et al. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors reassessment of risk factors for tumor recurrence. Ann Surg. 2008;248:857–62.

    Article  PubMed  Google Scholar 

  113. Guba M, Yezhelyev M, Eichhorn ME, et al. Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF. Blood. 2005;105:4463–9.

    Article  PubMed  CAS  Google Scholar 

  114. Toso C, Meeberg GA, Bigam DL, et al. De novo sirolimus based imunosuppression after liver transplantation for hepatocellular carcinoma: long term outcomes and side effects. Transplantation. 2007;83:1162–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Liver Unit, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, B15 2TH, UK

    P. Puneet, M. T. P. R. Perera & Darius F. Mirza

Authors
  1. P. Puneet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. T. P. R. Perera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Darius F. Mirza
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Darius F. Mirza.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Puneet, P., Perera, M.T.P.R. & Mirza, D.F. Current opinion on the role of resection and liver transplantation for hepatocellular cancer. Indian J Gastroenterol 31, 89–99 (2012). https://doi.org/10.1007/s12664-012-0200-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-012-0200-6

Keywords

Search

Navigation